European Urology Open Science (Jul 2020)

Spironolactone use is associated with lower risk of prostate cancer

  • K. Beckmann,
  • H. Garmo,
  • B. Lindahl,
  • L. Holmberg,
  • P. Stattin,
  • J. Adolfsson,
  • K. Cruickshank,
  • M. Van Hemelrijck

Journal volume & issue
Vol. 19
p. e262

Abstract

Read online

No abstracts available.